A B S T R A C T 36 systemic lupus erythematosus patients with native DNA binding activity (nDNA-BA) in the serum and subepidermal immunoglobulin deposits were studied to determine the relationship of the immunoglobulin (Ig) class distribution of serum nDNA-BA to the clinical characteristics oftheir disease and to the Ig class present at the dermal-epidermal junction (DEJ). The patients with predominantly (86-98%) IgM nDNA-BA in the serum had less active disease, mild or no renal involvement, and longer survival than those with predominantly (51-95%) IgG nDNA-BA in the serum. Renal biopsies in eight patients with predominantly IgM nDNA-BA in the serum showed relatively benign histologic changes in the kidney. In contrast, renal tissue from 23 patients with predominantly IgG nDNA-BA showed more severe histologic changes. All patients had multiple skin biopsies. Patients (SLE).1 Such antibodies play a role in some ofthe tissue injury that occurs in this disease and are generally associated with disease activity, renal involvement, and a poorer prognosis (1, 2) . Results of elution studies in patients with lupus nephritis have indicated that DNAanti-DNA complexes are deposited in the glomerulus in this disease (2) . Antibodies to nuclear antigens in SLE are heterogeneous and may variably react with single-or doublestranded DNA, RNA, nucleoprotein, or polynucleotides (3). They may be found in each of the major immunoglobulin classes (4) as well as IgG subclasses (5) . A predominance of IgG antibodies high in complement-fixing activity has been observed among antinuclear antibodies in patients with active nephritis (6). Koffler et al. (2) found that active lupus nephritis was associated with deposition of 7S anti-DNA in the glomerulus, and Rothfield and Stollar (7) reported a close correlation between IgG antinuclear antibodies staining in a peripheral pattern, complement-fixing antibodies to DNA, and the presence of active disease. However, not all patients with SLE have detectable anti-DNA antibodies and some who have such antibodies do not have renal disease (6) .
The diversity and heterogeneity of autoantibodies in SLE implies that as yet unidentified factors, such as genetic or viral factors, may restrict or define the immunologic responses of individual patients. Recently Papoian et al. (8) observed that male NZBxNZW F, hybrid (B/W) mice, which have more benign disease and longer survival than the female mice, demonstrate a late development of IgG anti-DNA antibody. Gilliam (9) has moreover observed that the class of Ig deposited at the dermal-epidermal junction (DEJ) in B/W mice parallels these observations in the serum. Thus, it seems likely that factors which control the nature of the anti-DNA response in SLE may influence the prognosis of the disease.
In the present study, the Ig classes of native DNA binding activity (nDNA-BA) in the serum of SLE patients were determined and compared with the clinical and laboratory features of the patients as well as with the classes of Ig deposited at the DEJ.
METHODS
Patients. 36 patients who satisfied the preliminary criteria for the diagnosis of SLE (10) and additional criteria required for this study were examined by one or more of the authors over a period of approximately 5 yr. The additional criteria were as follows: (a) presence of antibodies to native DNA on at least one occasion; (b) presence of Ig deposits at the DEJ of clinically normal skin; (c) absence of significant amounts of anti-ribonucleoprotein antibody in the serum; and (d) absence of advanced renal failure or history of treatment with cytotoxic agents at the time initially studied. The mean age of the SLE patients was 28.4 yr (13-59 yr). 30 were females and 6 males; 28 were black, 6 were white, and 2 were Latin-American. Duration of disease was 16.6 mo (2-60 mo). Duration of follow-up was 27.3 mo (6-56 mo). 11 were receiving prednisolone at the time of study in an average dosage of 25 mg/day.
Skin biopsy and immunofluorescent studies. 3-mm punch biopsies were obtained from the light protected uninvolved skin of the medial surface of the volar forearm. Processing of the tissue and immunofluorescent tests were carried out as previously described (11) .
DNA preparations. The labeled DNA used was a purified thymine [2- (14) .
Preparation ofanti--y and anti-,u antibodies. Antibodies to chromatographically purified IgG and IgM were raised in rabbits and the serum precipitated with 50% ammonium sulfate. The redissolved precipitate was dialyzed against phosphatebuffered saline and then passed through a Sepharose column to which either purified IgG or IgM had been bound by the cyanogen bromide method (15) . After washing the columns with phosphate-buffered saline, the antibodies to either IgG or IgM were recovered by acid elution with 0.1 M glycine HCI, pH 3.2. To ensure specificity and remove anti-light chain activity, the anti-IgG antibodies were incubated with SepharoseIgM and the anti-IgM antibodies with Sepharose-IgG. The antibodies recovered were then tested by Ouchterlony diffusion for reactivity with IgG, IgM, and whole human serum. Anti-IgG preparations reacted only with IgG and showed a single line ofidentity against whole serum. Anti-IgM preparations reacted only with IgM but also had a faint nonidentical line against whole serum. These antibody preparations are subsequently referred to below as anti-y and anti-IL antibodies.
The anti-y and anti-,u preparations were individually coupled to Sepharose by the cyanogen bromide method. Specificity of the Sepharose-bound anti-IL and Sepharose-bound anti-y was determined by incubation with 125I-IgG and 125j_
IgM. Greater than 98% of 1251-IgG in a preparation of human IgG (10 mg/ml) was removed by the Sepharose-bound anti-y and only 11% by the Sepharose-bound anti-I,. 95% of the 125I-IgM in a preparation ofhuman IgM (3 mg/ml) was removed by Sepharose-bound anti-,u and only 7% by Sepharose-bound anti-y. To evaluate the accuracy of the immunoabsorption procedure, results were compared with those obtained by fractionation ofthe sera by Sephadex G-200 chromatography and by 10-40% sucrose density ultracentrifugation. Table I shows a comparison of the findings obtained by the three methods in 14 patients. It can be seen that fractionation of the sera by the chromatographic and sucrose density methods followed by assay of nDNA-BA of individual fractions yielded results which agreed favorably with the immunoabsorption method. Fig. 2 Table I for comparison of nDNA-BA measurements). Note that the distribution ofnDNA-BA corresponds to the distribution ofIgM and IgG in the separated fractions.
Measurement of IgM and
In Table II , the characteristics of the patients with differing class distribution of nDNA-BA are compared. It is seen that there is no significant difference in age, sex, race, duration of disease, or prior therapy in the two groups. Fig. 3 presents the disease activity scores of each patient at the time that the serum was examined for the Ig class of nDNA-BA. In the IgG nDNA-BA group the median activity score was 6.2 (range 1-8). In the IgM nDNA-BA group the median score was 2.0 (range 1-4). This difference, which is highly significant (P < 0.001),
indicates that clinical activity in SLE is associated with the presence of IgG anti-DNA and that clinically inactive patients tend to have most or all of their anti-DNA in the IgM class.
Ig class distribution of nDNA-BA and renal status. Relationship between nDNA-BA in immunoglobulin classes and nDNA-BA in whole serum. As shown in Fig. 6 , sera in which nDNA-BA was present predominantly (over 80% of the total serum activity) in the IgM class had a lower nDNA-BA than sera with nDNA-BA predominantly (over 51%) in the IgG class.
Total nDNA-BA was 5.4±+1.1 ug/ml for the predominantly IgM nDNA-BA group and 9.7±1.7 ug/ml for the predominantly IgG nDNA-BA group. However, there was considerable overlap between the two groups and the difference was not statistically significant (P = 0.089).
To determine whether IgG nDNA-BA was related to severity of disease independently of total nDNA-BA, the total nDNA-BA values of eight patients in the predominantly IgG nDNA-BA group were paired with those of eight patients in the predominantly IgM nDNA-BA group on the basis that their total nDNA-BA difrered by less than 1 ug/ml. Disease activity and incidence of serious renal disease were then compared in the two groups. The median activity score of the IgG DNA-BA group was greater than that of the IgM DNA-BA group, being 6.0 in the IgG group and 2.5 in the IgM group (P < 0.05). Furthermore, four of the eight patients in the IgG group had diffuse proliferative nephritis, while none of the eight patients in the IgM group had this type of nephritis (P = 0.038). These findings indicate that disease activity and serious renal disease were related to the presence of IgG nDNA-BA in the serum even in patients with relatively low total nDNA-BA.
tologic findings, and better renal function than observed in the patients with a majority of their DNA binding in the IgG fraction. Secondly, there was a good correlation between the Ig classes of nDNA-BA present in the serum and the Ig classes stained at the DEJ. The shift from IgM to IgG antibody synthesis for most antigens is dependent upon functioning thymus-derived (T) cells (16) . The effect of thymic regulatory cells on anti-DNA and anti-RNA antibody formation has been discussed in detail by Talal (17) . Thymectomized mice, lacking in T cells, react to thymus-dependent antigens by producing predominantly IgM rather than the expected IgG antibodies (18) . Congenitally athymic, nude mice spontaneously form predominantly IgM antinuclear antibodies (19) , suggesting the importance of thymic function in the production of IgG antibodies to such nuclear antigens. Roubinian et al. (20) recently studied the IgG to IgM ratio of anti-DNA antibodies in male B/W F1 hybrid mice and found that although the magnitude of the antibody titer was heightened by thymectomy, there was no effect on the timing of the switch from IgM to IgG anti-DNA formation which occurs later in the male than in the female. However, combined splenectomy and thymectomy resulted in an increased IgG response to DNA, suggesting that antibodies to DNA are under the control of regulatory cells present in both the thymus and spleen.
In certain strains of inbred mice, both the magnitude and Ig class of antibody response to nucleic acid antigens appear to be genetically regulated. SJL/J and AKR/Cu mice who were high responders to proteincomplexed denatured DNA (21) The observation that diffuse proliferative glomerulonephritis did not occur in the IgM nDNA-BA group but did occur in 61% of the patients with predominantly IgG nDNA-BA is of major interest. Since the age, race, sex, and duration of disease were similar in both groups, it would appear that the Ig class of nDNA-BA was a critical factor in determining whether diffuse proliferative glomerulonephritis developed. This difference was not a result of prior therapy since only 2 of 10 patients in the group without PGN had received prior treatment, and in these patients only low doses of prednisolone had been administered.
There is evidence that differences in antigen-antibody affinity and solubility between immune complexes formed by IgG and IgM anti-DNA may determine the differing incidence of nephritis observed in the presence of the two types of anti-DNA. It has been proposed that chronic immune complex disease is due to the presence of immune complexes containing low affinity antibody (23, 24) which tends to escape immune elimination. However, Winfield et al. (25) have recently shown that although the anti-DNA in the serum of lupus nephritis patients has low avidity, that extracted from the kidney has high avidity. Johnson et al. (26) observed that SLE patients with persistently negative DNA precipitation tests, as measured by counterimmunoelectrophoresis, had a high incidence of nephritis, while patients with consistently positive DNA precipitation tests had a very low incidence of nephritis thus demonstrating an association of nephritis with greater solubility of DNA:anti-DNA complexes.
There is little data on the relative capacities of IgG and IgM anti-DNA to form soluble as opposed to precipitating anti-DNA complexes. Dorsch and Barnett (27) 
